Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000123 | histone acetyltransferase complex | 4 | 6 |
GO:0031248 | protein acetyltransferase complex | 3 | 6 |
GO:0032991 | protein-containing complex | 1 | 6 |
GO:0072487 | MSL complex | 6 | 6 |
GO:0140535 | intracellular protein-containing complex | 2 | 6 |
GO:1902493 | acetyltransferase complex | 4 | 6 |
GO:1902494 | catalytic complex | 2 | 6 |
GO:1902562 | H4 histone acetyltransferase complex | 5 | 6 |
GO:1990234 | transferase complex | 3 | 6 |
Related structures:
AlphaFold database: Q4Q053
Term | Name | Level | Count |
---|---|---|---|
GO:0006355 | regulation of DNA-templated transcription | 6 | 10 |
GO:0006357 | regulation of transcription by RNA polymerase II | 7 | 2 |
GO:0009889 | regulation of biosynthetic process | 4 | 10 |
GO:0009890 | negative regulation of biosynthetic process | 5 | 2 |
GO:0009891 | positive regulation of biosynthetic process | 5 | 2 |
GO:0009892 | negative regulation of metabolic process | 4 | 2 |
GO:0009893 | positive regulation of metabolic process | 4 | 2 |
GO:0010468 | regulation of gene expression | 5 | 10 |
GO:0010556 | regulation of macromolecule biosynthetic process | 5 | 10 |
GO:0010557 | positive regulation of macromolecule biosynthetic process | 6 | 2 |
GO:0010558 | negative regulation of macromolecule biosynthetic process | 6 | 2 |
GO:0010604 | positive regulation of macromolecule metabolic process | 5 | 2 |
GO:0010605 | negative regulation of macromolecule metabolic process | 5 | 2 |
GO:0019219 | regulation of nucleobase-containing compound metabolic process | 5 | 10 |
GO:0019222 | regulation of metabolic process | 3 | 10 |
GO:0031323 | regulation of cellular metabolic process | 4 | 10 |
GO:0031324 | negative regulation of cellular metabolic process | 5 | 2 |
GO:0031325 | positive regulation of cellular metabolic process | 5 | 2 |
GO:0031326 | regulation of cellular biosynthetic process | 5 | 10 |
GO:0031327 | negative regulation of cellular biosynthetic process | 6 | 2 |
GO:0031328 | positive regulation of cellular biosynthetic process | 6 | 2 |
GO:0045892 | negative regulation of DNA-templated transcription | 7 | 2 |
GO:0045893 | positive regulation of DNA-templated transcription | 7 | 2 |
GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 6 | 2 |
GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | 6 | 2 |
GO:0045944 | positive regulation of transcription by RNA polymerase II | 8 | 2 |
GO:0048518 | positive regulation of biological process | 3 | 2 |
GO:0048519 | negative regulation of biological process | 3 | 2 |
GO:0048522 | positive regulation of cellular process | 4 | 2 |
GO:0048523 | negative regulation of cellular process | 4 | 2 |
GO:0050789 | regulation of biological process | 2 | 10 |
GO:0050794 | regulation of cellular process | 3 | 10 |
GO:0051171 | regulation of nitrogen compound metabolic process | 4 | 10 |
GO:0051172 | negative regulation of nitrogen compound metabolic process | 5 | 2 |
GO:0051173 | positive regulation of nitrogen compound metabolic process | 5 | 2 |
GO:0051252 | regulation of RNA metabolic process | 5 | 10 |
GO:0051253 | negative regulation of RNA metabolic process | 6 | 2 |
GO:0051254 | positive regulation of RNA metabolic process | 6 | 2 |
GO:0060255 | regulation of macromolecule metabolic process | 4 | 10 |
GO:0065007 | biological regulation | 1 | 10 |
GO:0080090 | regulation of primary metabolic process | 4 | 10 |
GO:1902679 | negative regulation of RNA biosynthetic process | 7 | 2 |
GO:1902680 | positive regulation of RNA biosynthetic process | 7 | 2 |
GO:1903506 | regulation of nucleic acid-templated transcription | 7 | 10 |
GO:1903507 | negative regulation of nucleic acid-templated transcription | 8 | 2 |
GO:1903508 | positive regulation of nucleic acid-templated transcription | 8 | 2 |
GO:2001141 | regulation of RNA biosynthetic process | 6 | 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003712 | transcription coregulator activity | 2 | 2 |
GO:0003824 | catalytic activity | 1 | 10 |
GO:0004402 | histone acetyltransferase activity | 4 | 10 |
GO:0005488 | binding | 1 | 2 |
GO:0005515 | protein binding | 2 | 2 |
GO:0008080 | N-acetyltransferase activity | 6 | 10 |
GO:0010485 | histone H4 acetyltransferase activity | 5 | 2 |
GO:0016407 | acetyltransferase activity | 5 | 10 |
GO:0016410 | N-acyltransferase activity | 5 | 10 |
GO:0016740 | transferase activity | 2 | 10 |
GO:0016746 | acyltransferase activity | 3 | 10 |
GO:0016747 | acyltransferase activity, transferring groups other than amino-acyl groups | 4 | 10 |
GO:0034212 | peptide N-acetyltransferase activity | 7 | 10 |
GO:0042393 | histone binding | 3 | 2 |
GO:0046972 | histone H4K16 acetyltransferase activity | 6 | 2 |
GO:0061733 | peptide-lysine-N-acetyltransferase activity | 3 | 10 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 10 |
GO:0140110 | transcription regulator activity | 1 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 194 | 196 | PF00675 | 0.362 |
CLV_NRD_NRD_1 | 259 | 261 | PF00675 | 0.531 |
CLV_NRD_NRD_1 | 265 | 267 | PF00675 | 0.485 |
CLV_NRD_NRD_1 | 73 | 75 | PF00675 | 0.266 |
CLV_NRD_NRD_1 | 82 | 84 | PF00675 | 0.265 |
CLV_NRD_NRD_1 | 92 | 94 | PF00675 | 0.267 |
CLV_PCSK_KEX2_1 | 259 | 261 | PF00082 | 0.492 |
CLV_PCSK_KEX2_1 | 264 | 266 | PF00082 | 0.485 |
CLV_PCSK_KEX2_1 | 73 | 75 | PF00082 | 0.292 |
CLV_PCSK_KEX2_1 | 92 | 94 | PF00082 | 0.190 |
CLV_PCSK_PC1ET2_1 | 259 | 261 | PF00082 | 0.474 |
CLV_PCSK_PC1ET2_1 | 264 | 266 | PF00082 | 0.460 |
CLV_PCSK_PC7_1 | 260 | 266 | PF00082 | 0.439 |
CLV_PCSK_PC7_1 | 69 | 75 | PF00082 | 0.290 |
CLV_PCSK_SKI1_1 | 260 | 264 | PF00082 | 0.509 |
CLV_PCSK_SKI1_1 | 99 | 103 | PF00082 | 0.278 |
DEG_MDM2_SWIB_1 | 194 | 202 | PF02201 | 0.464 |
DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.549 |
DOC_CKS1_1 | 179 | 184 | PF01111 | 0.565 |
DOC_MAPK_gen_1 | 73 | 79 | PF00069 | 0.464 |
DOC_MAPK_MEF2A_6 | 247 | 254 | PF00069 | 0.541 |
DOC_PP1_RVXF_1 | 269 | 275 | PF00149 | 0.541 |
DOC_PP4_FxxP_1 | 60 | 63 | PF00568 | 0.430 |
DOC_USP7_MATH_1 | 11 | 15 | PF00917 | 0.446 |
DOC_USP7_MATH_1 | 155 | 159 | PF00917 | 0.484 |
DOC_WW_Pin1_4 | 178 | 183 | PF00397 | 0.464 |
DOC_WW_Pin1_4 | 211 | 216 | PF00397 | 0.510 |
DOC_WW_Pin1_4 | 7 | 12 | PF00397 | 0.510 |
LIG_14-3-3_CanoR_1 | 12 | 16 | PF00244 | 0.483 |
LIG_14-3-3_CanoR_1 | 167 | 171 | PF00244 | 0.565 |
LIG_BRCT_BRCA1_1 | 23 | 27 | PF00533 | 0.491 |
LIG_BRCT_BRCA1_1 | 56 | 60 | PF00533 | 0.435 |
LIG_BRCT_BRCA1_1 | 97 | 101 | PF00533 | 0.505 |
LIG_Clathr_ClatBox_1 | 100 | 104 | PF01394 | 0.565 |
LIG_Clathr_ClatBox_1 | 119 | 123 | PF01394 | 0.329 |
LIG_CSL_BTD_1 | 60 | 63 | PF09270 | 0.430 |
LIG_deltaCOP1_diTrp_1 | 136 | 141 | PF00928 | 0.398 |
LIG_FHA_1 | 30 | 36 | PF00498 | 0.463 |
LIG_FHA_2 | 105 | 111 | PF00498 | 0.468 |
LIG_FHA_2 | 215 | 221 | PF00498 | 0.539 |
LIG_LIR_Apic_2 | 57 | 63 | PF02991 | 0.456 |
LIG_LIR_Gen_1 | 115 | 122 | PF02991 | 0.514 |
LIG_LIR_Gen_1 | 124 | 133 | PF02991 | 0.445 |
LIG_LIR_Gen_1 | 138 | 147 | PF02991 | 0.482 |
LIG_LIR_Gen_1 | 201 | 209 | PF02991 | 0.482 |
LIG_LIR_Nem_3 | 110 | 116 | PF02991 | 0.464 |
LIG_LIR_Nem_3 | 124 | 130 | PF02991 | 0.464 |
LIG_LIR_Nem_3 | 14 | 18 | PF02991 | 0.447 |
LIG_LIR_Nem_3 | 158 | 164 | PF02991 | 0.505 |
LIG_LIR_Nem_3 | 201 | 207 | PF02991 | 0.482 |
LIG_Pex14_2 | 116 | 120 | PF04695 | 0.475 |
LIG_Pex14_2 | 129 | 133 | PF04695 | 0.441 |
LIG_Pex14_2 | 194 | 198 | PF04695 | 0.464 |
LIG_SH2_SRC | 170 | 173 | PF00017 | 0.482 |
LIG_SH2_STAT5 | 132 | 135 | PF00017 | 0.464 |
LIG_SH2_STAT5 | 34 | 37 | PF00017 | 0.400 |
LIG_SH2_STAT5 | 41 | 44 | PF00017 | 0.356 |
LIG_SH3_3 | 149 | 155 | PF00018 | 0.450 |
LIG_SH3_3 | 176 | 182 | PF00018 | 0.469 |
LIG_SH3_3 | 5 | 11 | PF00018 | 0.511 |
LIG_SUMO_SIM_anti_2 | 148 | 154 | PF11976 | 0.464 |
LIG_SUMO_SIM_anti_2 | 238 | 244 | PF11976 | 0.458 |
LIG_SUMO_SIM_par_1 | 214 | 220 | PF11976 | 0.482 |
LIG_SUMO_SIM_par_1 | 230 | 238 | PF11976 | 0.482 |
LIG_UBA3_1 | 96 | 105 | PF00899 | 0.576 |
LIG_WRC_WIRS_1 | 113 | 118 | PF05994 | 0.565 |
LIG_WRC_WIRS_1 | 161 | 166 | PF05994 | 0.510 |
LIG_WRC_WIRS_1 | 40 | 45 | PF05994 | 0.439 |
MOD_CDK_SPK_2 | 7 | 12 | PF00069 | 0.510 |
MOD_CDK_SPxK_1 | 178 | 184 | PF00069 | 0.464 |
MOD_CK1_1 | 139 | 145 | PF00069 | 0.565 |
MOD_CK1_1 | 214 | 220 | PF00069 | 0.486 |
MOD_CK1_1 | 222 | 228 | PF00069 | 0.444 |
MOD_CK2_1 | 214 | 220 | PF00069 | 0.491 |
MOD_Cter_Amidation | 81 | 84 | PF01082 | 0.273 |
MOD_GlcNHglycan | 188 | 191 | PF01048 | 0.296 |
MOD_GlcNHglycan | 275 | 278 | PF01048 | 0.654 |
MOD_GSK3_1 | 131 | 138 | PF00069 | 0.518 |
MOD_GSK3_1 | 139 | 146 | PF00069 | 0.491 |
MOD_GSK3_1 | 219 | 226 | PF00069 | 0.554 |
MOD_GSK3_1 | 272 | 279 | PF00069 | 0.596 |
MOD_GSK3_1 | 35 | 42 | PF00069 | 0.354 |
MOD_GSK3_1 | 7 | 14 | PF00069 | 0.452 |
MOD_N-GLC_1 | 254 | 259 | PF02516 | 0.571 |
MOD_NEK2_1 | 186 | 191 | PF00069 | 0.528 |
MOD_NEK2_1 | 272 | 277 | PF00069 | 0.520 |
MOD_NEK2_1 | 35 | 40 | PF00069 | 0.448 |
MOD_OFUCOSY | 143 | 149 | PF10250 | 0.264 |
MOD_PKA_2 | 11 | 17 | PF00069 | 0.523 |
MOD_PKA_2 | 166 | 172 | PF00069 | 0.565 |
MOD_PKA_2 | 29 | 35 | PF00069 | 0.223 |
MOD_PKA_2 | 54 | 60 | PF00069 | 0.525 |
MOD_Plk_2-3 | 104 | 110 | PF00069 | 0.464 |
MOD_Plk_4 | 160 | 166 | PF00069 | 0.490 |
MOD_Plk_4 | 22 | 28 | PF00069 | 0.567 |
MOD_Plk_4 | 223 | 229 | PF00069 | 0.543 |
MOD_Plk_4 | 29 | 35 | PF00069 | 0.465 |
MOD_ProDKin_1 | 178 | 184 | PF00069 | 0.464 |
MOD_ProDKin_1 | 211 | 217 | PF00069 | 0.510 |
MOD_ProDKin_1 | 7 | 13 | PF00069 | 0.511 |
TRG_DiLeu_BaEn_1 | 258 | 263 | PF01217 | 0.590 |
TRG_DiLeu_BaEn_2 | 124 | 130 | PF01217 | 0.565 |
TRG_DiLeu_BaLyEn_6 | 247 | 252 | PF01217 | 0.546 |
TRG_ENDOCYTIC_2 | 161 | 164 | PF00928 | 0.464 |
TRG_ER_diArg_1 | 265 | 267 | PF00400 | 0.570 |
TRG_ER_diArg_1 | 73 | 75 | PF00400 | 0.503 |
TRG_ER_diArg_1 | 92 | 94 | PF00400 | 0.427 |
TRG_NES_CRM1_1 | 220 | 231 | PF08389 | 0.510 |
TRG_NLS_MonoExtN_4 | 261 | 268 | PF00514 | 0.385 |
TRG_Pf-PMV_PEXEL_1 | 265 | 270 | PF00026 | 0.579 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0S4KI17 | Bodo saltans | 32% | 100% |
A0A1X0NLZ1 | Trypanosomatidae | 50% | 99% |
A0A3R7KL17 | Trypanosoma rangeli | 52% | 99% |
A4HQM2 | Leishmania braziliensis | 84% | 95% |
A4ICE0 | Leishmania infantum | 94% | 100% |
D0A3S6 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 50% | 99% |
E9AUD7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 93% | 100% |
P40963 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 26% | 83% |
Q10325 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 39% | 69% |
V5BHQ1 | Trypanosoma cruzi | 52% | 100% |
W0G5Y6 | Leishmania donovani | 94% | 100% |